H. F. Lui
Author pages are created from data sourced from our academic publisher partnerships and public sources.
Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations
- S. Sarin, A. Kumar, +32 authors Asian Pacific Association for the Study of the Liver Wor Hypertension
- Hepatology international
- 19 February 2011
BackgroundAcute variceal bleeding (AVB) is a medical emergency and associated with a mortality of 20% at 6 weeks. Significant advances have occurred in the recent past and hence there is a need to… Expand
Management of pyogenic liver abscesses - percutaneous or open drainage?
This pictorial essay aims to review the literature on the management of pyogenic liver abscess, focusing on the choice of drainage. Articles on the treatment of pyogenic liver abscess, accessed… Expand
Clinical mimicry of hepatocellular carcinoma: imaging-pathological correlation.
This pictorial essay aims to show the clinical mimicry of hepatocellular carcinoma (HCC) and its diagnostic difficulty, and to create awareness among clinicians and radiologists of potential… Expand
Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection.
Imatinib mesylate (Gleevec) is widely-used in the treatment of chronic myeloid leukaemia (CML) and gastrointestinal stromal tumour. Up to four percent of patients treated with imatinib may develop… Expand
Treatment of Hepatitis B in Decompensated Liver Cirrhosis
Chronic hepatitis B infection progresses from an asymptomatic persistently infected state to chronic hepatitis, cirrhosis, decompensated liver disease, and/or hepatocellular carcinoma. About 3% of… Expand
Change in model for end-stage liver disease score at two weeks, as an indicator of mortality or liver transplantation at 60 days in acute-on-chronic liver failure
- R. Kumar, T. L. Krishnamoorthy, H. K. Tan, H. F. Lui, W. C. Chow
- Gastroenterology report
- 11 November 2014
Background: Acute-on-chronic liver failure (ACLF) is characterised by a sudden deterioration of underlying chronic liver disease, resulting in increased rates of mortality and liver transplantation.… Expand
A Study Into the Risk of Exacerbation of Chronic Hepatitis B After Liver Resection for Hepatocellular Carcinoma
- T. J. Thia, H. F. Lui, +5 authors W. C. Chow
- Journal of Gastrointestinal Surgery
- 14 March 2007
Liver resection is commonly performed for solitary hepatocellular carcinoma (HCC) in well-compensated cirrhotic and noncirrhotic patients. Data concerning exacerbation of chronic hepatitis B (ECHB)… Expand
Epidemiology and Prognosis of Paraneoplastic Syndromes in Hepatocellular Carcinoma
Background. Paraneoplastic syndromes (PNS) such as hypercalcaemia, hypercholesterolaemia, and erythrocytosis have been described in hepatocellular carcinoma (HCC). Aims. (1) To examine the… Expand
MARS therapy in critically ill patients with advanced malignancy: a clinical and technical report.
BACKGROUND/METHODS Molecular Adsorbent Recirculating System (MARS) was used in three consecutive critically ill patients at the Singapore General Hospital with advanced malignancy and acute liver… Expand
Chronic Administration of Losartan, an Angiotensin II Receptor Antagonist, is not Effective in Reducing Portal Pressure in Patients with Preascitic Cirrhosis
- D. Tripathi, G. Therapondos, H. F. Lui, N. Johnston, D. Webb, P. Hayes
- American Journal of Gastroenterology
- 1 February 2004
OBJECTIVES:Plasma angiotensin II (ANG II) concentrations are elevated in cirrhosis and have been implicated as a cause of portal hypertension. We aimed to study both the systemic and portal… Expand